Brief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
03/05/2024 21:35
May 3 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS INC - ON MAY 2, NASDAQ NOTIFIED
COMPANY
THAT IT HAS NOT REGAINED COMPLIANCE WITH MINIMUM BID PRICE
REQUIREMENT
* NEUBASE THERAPEUTICS - EXPECTS TRADING IN CO'S COMMON
STOCK
WILL BE SUSPENDED UPON OPENING OF BUSINESS ON MAY 13
Source text for Eikon: ID:n0001104659-24-056957
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet